Edward M. Kaye MD - 03 Jan 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Kaye
Issuer symbol
CYTK
Transactions as of
03 Jan 2023
Net transactions value
+$11,221
Form type
4
Filing time
04 Jan 2023, 17:33:21 UTC
Previous filing
09 Dec 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $11,221 +253 +2% $44.35 13,049 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $44.35, representing the Issuer's closing stock price on January 3, 2023.